Classification Information
Disease-modifying therapeutics, namely, therapeutic pharmaceuticals and biopharmaceuticals for treatment of amyloid conditions in mammals; therapeutics in the form of pharmaceuticals and biopharmaceuticals for the purpose of inhibiting toxicity and protein aggregation
Pharmaceuticals